Pabón I P, Díaz L P, Grande C, de la Cal López M A
Servicio de Radiología Vascular e Intervencionista, Hospital Universitario de Getafe, Madrid, Spain.
J Vasc Interv Radiol. 2001 Jan;12(1):67-71. doi: 10.1016/s1051-0443(07)61406-7.
To assess technical problems related to implantation of a polyurethane stent to treat obstructive epiphora, and to assess the long-term patency of the nasolacrimal system.
Fluoroscopically guided placement of a polyurethane nasolacrimal stent was performed in 70 obstructed lacrimal systems of 62 patients with grade 3-4 obstructive epiphora. Follow-up was conducted for 1-20 months (average, 11.3 months). The obstruction was at the lacrimal sac in six systems, at the junction between the lacrimal sac and the nasolacrimal duct in 60 systems, and at the nasolacrimal duct in four systems. The cause of the obstruction was idiopathic in all cases but was probably residual to dacryocystitis.
Of these 70 procedures, stent placement was technically successful in 61 systems (87%). On long-term follow-up, 41 (67.2%) stents remained in place, with resolution or clinical improvement, and 18 (29.5%) stents were removed (because of occlusion in 17 systems), with stent malpositioning in the duct in six cases. There were seven cases of malpositioning in all. Statistical analysis was performed to evaluate patency, compare patency in properly positioned stents and malpositioned stents, and establish the relationship between malpositioning and the need for irrigation to maintain stent patency. Of the total 70 stents originally placed, 41 (58.6%) were still in place and functional at long-term follow-up. At 1 year, 73% of properly positioned stents remained patent versus 0% of improperly positioned stents. Median stent patency in the former group was 20 months and was 1 month in the latter group (P = .00002). Eleven percent of properly positioned stents required irrigation versus 57% of incorrectly positioned stents (P = .01).
After follow-up for 1 year, recurrence of epiphora brought on by stent obstruction was 28%. Early stent blockage and the need for periodic irrigation may be indicative of malpositioning of the stent.
评估与植入聚氨酯支架治疗阻塞性泪溢相关的技术问题,并评估鼻泪系统的长期通畅情况。
在62例3 - 4级阻塞性泪溢患者的70个阻塞性泪道系统中,在荧光透视引导下植入聚氨酯鼻泪支架。随访1 - 20个月(平均11.3个月)。阻塞部位在6个泪囊系统、60个泪囊与鼻泪管交界处系统以及4个鼻泪管系统。所有病例阻塞原因均为特发性,但可能与泪囊炎残留有关。
在这70例手术中,61个系统(87%)的支架植入在技术上成功。长期随访时,41个(67.2%)支架保留在位,溢泪症状缓解或临床改善,18个(29.5%)支架被取出(17个系统因阻塞,6例支架在泪道中位置不当)。总共7例位置不当。进行统计分析以评估通畅情况,比较位置正确和位置不当的支架的通畅情况,并确定位置不当与维持支架通畅所需冲洗之间的关系。最初植入的70个支架中,41个(58.6%)在长期随访时仍在位且功能正常。1年时,位置正确的支架73%保持通畅,而位置不当的支架通畅率为0%。前一组支架通畅的中位时间为20个月,后一组为1个月(P = .00002)。位置正确的支架11%需要冲洗,而位置不正确的支架为57%(P = .01)。
随访1年后,支架阻塞导致的泪溢复发率为28%。早期支架阻塞和定期冲洗的需求可能表明支架位置不当。